MariMed Inc. (MRMD)
OTCMKTS · Delayed Price · Currency is USD
0.0975
-0.0005 (-0.47%)
Aug 1, 2025, 3:51 PM EDT
ATSG Market Cap
MariMed has a market cap or net worth of $38.24 million as of August 1, 2025. Its market cap has decreased by -39.07% in one year.
Market Cap
38.24M
Enterprise Value
131.50M
Revenue
157.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since May 12, 2017, MariMed's market cap has increased from 25.70M to 38.24M, an increase of 48.79%. That is a compound annual growth rate of 4.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 38.24M | -13.44% |
| Dec 31, 2024 | 44.17M | -57.26% |
| Dec 29, 2023 | 103.36M | -14.51% |
| Dec 30, 2022 | 120.90M | -58.11% |
| Dec 31, 2021 | 288.61M | 101.45% |
| Dec 31, 2020 | 143.26M | 3.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| CytoDyn | 371.08M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |